The impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: An open-label, randomized clinical trial
Luyi Chen(Sir Run Run Shaw Hospital), Shujie Chen(Sir Run Run Shaw Hospital), Jiamin He(Sir Run Run Shaw Hospital), Kan Wang(Sir Run Run Shaw Hospital), Hua Chu(Sir Run Run Shaw Hospital), Sanchuan Lai(Sir Run Run Shaw Hospital), Jianmin Si(Zhejiang University), Tingting Su(Sir Run Run Shaw Hospital), Yanqin Long(Sir Run Run Shaw Hospital), Lan Wang(Sir Run Run Shaw Hospital), Yujia Chen(Guizhou University), Wenfang Zheng(Tongji University), Bixia Huang(Zhejiang Hospital), Wenli Xu(Sir Run Run Shaw Hospital), Allen Lee(Michigan Medicine)
Cited by 214
Related Papers
Strain engineering of <scp>two‐dimensional</scp> materials: Methods, properties, and applications
|InfoMat|2021|468
Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer
|Cell|2024|372
<i>Fusobacterium nucleatum</i> promotes colorectal cancer cells adhesion to endothelial cells and facilitates extravasation and metastasis by inducing ALPK1/NF-κB/ICAM1 axis
|Gut Microbes|2022|194